Management of brain tumors presenting in pregnancy: a case series and systematic review.

in American journal of obstetrics & gynecology MFM by Adrian J Rodrigues, Anne R Waldrop, Sanaa Suharwardy, Maurice L Druzin, Michael Iv, Jessica R Ansari, Sarah A Stone, Richard A Jaffe, Michael C Jin, Gordon Li, Melanie Hayden-Gephart

TLDR

  • The study reviews the management of brain tumors in pregnant women, emphasizing the need for individualized care under a multidisciplinary team.
  • The study found that 89% of patients delivered healthy newborns and 56% required neurosurgical procedures during pregnancy.
  • The study highlights the importance of considering the physiological and pharmacodynamic changes of pregnancy when treating brain tumors in pregnant women.

Abstract

Patients who present with brain tumors during pregnancy require unique imaging and neurosurgical, obstetrical, and anesthetic considerations. Here, we review the literature and discuss the management of patients who present with brain tumors during pregnancy. Between 2009 and 2019, 9 patients were diagnosed at our institution with brain tumors during pregnancy. Clinical information was extracted from the electronic medical records. The median age at presentation was 29 years (range, 25-38 years). The most common symptoms at presentation included headache (n=5), visual changes (n=4), hemiparesis (n=3), and seizures (n=3). The median gestational age at presentation was 20.5 weeks (range, 11-37 weeks). Of note, 8 patients (89%) delivered healthy newborns, and 1 patient terminated her pregnancy. In addition, 5 patients (56%) required neurosurgical procedures during pregnancy (gestational ages, 14-37 weeks) because of disease progression (n=2) or neurologic instability (n=3). There was 1 episode of postneurosurgery morbidity (pulmonary embolism [PE]) and no surgical maternal mortality. The median length of follow-up was 15 months (range, 6-45 months). In cases demonstrating unstable or progressive neurosurgical status past the point of fetal viability, neurosurgical intervention should be considered. The physiological and pharmacodynamic changes of pregnancy substantially affect anesthetic management. Pregnancy termination should be discussed and offered to the patient when aggressive disease necessitates immediate treatment and the fetal gestational age remains previable, although neurologically stable patients may be able to continue the pregnancy to term. Ultimately, pregnant patients with brain tumors require an individualized approach to their care under the guidance of a multidisciplinary team.

Overview

  • The study reviews the management of patients who present with brain tumors during pregnancy, highlighting the need for unique imaging and neurosurgical, obstetrical, and anesthetic considerations.
  • The study presents clinical information from 9 patients diagnosed with brain tumors during pregnancy at a single institution between 2009 and 2019.
  • The primary objective is to discuss the management of patients with brain tumors during pregnancy, emphasizing the importance of individualized care under a multidisciplinary team.

Comparative Analysis & Findings

  • The study found that 89% of patients delivered healthy newborns, and 56% required neurosurgical procedures during pregnancy due to disease progression or neurologic instability.
  • There was one episode of postneurosurgery morbidity (pulmonary embolism) and no surgical maternal mortality.
  • The study found that even in cases of unstable or progressive neurosurgical status, neurosurgical intervention should be considered when the fetus becomes viable.

Implications and Future Directions

  • The study emphasizes the importance of individualized care for pregnant patients with brain tumors, taking into account the physiological and pharmacodynamic changes of pregnancy.
  • Future studies could explore the optimal timing and management of neurosurgical interventions during pregnancy, as well as the role of multidisciplinary care in improving outcomes.
  • The study highlights the need for further research on the management of brain tumors during pregnancy, particularly in cases where the fetal gestational age is previable.